Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Pharmaceutical companies have always provided patient assistance programs for the uninsured. But as health care costs rise and patients are subjected to more cost-sharing, pharmaceutical companies are finding the pool of needy patients is growing. AccessMED, a US Oncology subsidiary that provides patient access and drug reimbursement solutions to the pharmaceutical industry, hosted a Patient Access Summit last month to explore health care reform’s impact on patient access and discuss other hot topics such as REMS.

In this podcast interview, AccessMED’s Scott Dulitz and Rick Ford discuss key themes emerging from the Summit and answered a variety of questions about patient access issues for expensive drugs.

Share

Read More: http://feedproxy.google.com/~r/HealthBusinessBlog/~3/6mqhVDR6iXw/